Cocrystal Pharma Announces New Data on CC-31244 and Abstract Acceptance for Poster Presentation at the AASLD 2019 Liver Meeting

NEXT STORY
In Vitro Toxicology/Toxicity Testing Market Worth USD 14.4 Billion by 2025 – Exclusive Report by Meticulous Research®
PREV STORY
Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak as Chief Financial Officer and Further Strengthens Senior Executive Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Announces Non-Brokered Private Placement

author_avatar
NASDAQ Market News

Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline

Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043 ...

author_avatar
NASDAQ Market News

Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis

author_avatar
NASDAQ Market News